Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno
published in: Journal of Clinical Oncology
date of publication: 2001-03-01
language: English
main subject: acute myeloid leukemia, heterozygosity
Cites articles
There is nothing here
Article - wd:Q73567637